Skip to content
inentertainment.co.uk
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Edesa Biotech, Inc.
Edesa Biotech Announces Pricing of $25.0 Million Public Offering
August 19, 2026
Edesa Biotech Announces Proposed Public Offering
August 19, 2026
Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results
August 13, 2026
Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors
June 11, 2026
Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury
June 5, 2026
Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference
May 25, 2026
Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results
May 25, 2026
Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study
February 24, 2026
Edesa Biotech Reports Fiscal 1st Quarter 2026 Results
February 14, 2026